Marc Antony Serfaty

Summary

Affiliation: University College London
Country: UK

Publications

  1. doi A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood
    Marc Antony Serfaty
    Research Department of Mental Health Sciences Royal Free Campus, UCL Medical School, London, UK
    Int Clin Psychopharmacol 25:132-42. 2010
  2. doi Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial
    Marc Antony Serfaty
    Department of Mental Health Sciences, University College Medical School, Rowland Hill St, London NW3 2PF, England
    Arch Gen Psychiatry 66:1332-40. 2009

Detail Information

Publications2

  1. doi A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood
    Marc Antony Serfaty
    Research Department of Mental Health Sciences Royal Free Campus, UCL Medical School, London, UK
    Int Clin Psychopharmacol 25:132-42. 2010
    ..In conclusion, melatonin may be beneficial for treating MDD, it seems to be safe and well tolerated, but its potential for treating depression in people who do not wish to take antidepressants requires further evaluation...
  2. doi Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial
    Marc Antony Serfaty
    Department of Mental Health Sciences, University College Medical School, Rowland Hill St, London NW3 2PF, England
    Arch Gen Psychiatry 66:1332-40. 2009
    ..Despite this, older people are rarely offered psychological interventions, and only 3 randomized controlled trials of individual cognitive behavioral therapy (CBT) in a primary care setting have been published...